The effects of ZD6474, an inhibitor of VEGF signaling, on cutaneous wound healing in mice

Journal of Surgical Research

Volumn 129, Issue 2, 2005, Pages 251-259

  Ko, Jason ^a   Ross, Joel ^a   Awad, Hani ^a   Hurwitz, Herbert ^a   Klitzman, Bruce ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiogenesis inhibitor; VEGF; Wound healing; ZD6474

Indexed keywords

VANDETANIB; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EPITHELIUM; FEMALE; MICROVASCULARIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN FIBROSIS; SKIN INJURY; VASCULARIZATION; WOUND DEHISCENCE; WOUND HEALING;

ANIMALS; BODY WEIGHT; FEMALE; MICE; MICE, INBRED BALB C; MICROCIRCULATION; NEOVASCULARIZATION, PHYSIOLOGIC; PIPERIDINES; QUINAZOLINES; SIGNAL TRANSDUCTION; SKIN; STRESS, MECHANICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; WOUND HEALING; WOUNDS AND INJURIES;

EID: 29144510498     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2005.05.006     Document Type: Article

References (40)

1. J. Folkman Role of angiogenesis in tumor growth and metastasis Semin. Oncol. 29 2002 15
2. D. Hanahan, J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353
3. J.M. Cherrington, L.M. Strawn, L.K. Shawver New paradigms for the treatment of cancer The role of anti-angiogenesis agents Adv. Cancer Res. 79 2000 1
4. M. Meyer, M. Clauss, A. Lepple-Wienhues A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases EMBO J. 18 1999 363
5. H. Gille, J. Kowalski, B. Li Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants J. Biol. Chem. 276 2001 3222
6. H. Zeng, S. Sanyal, D. Mukhopadhyay Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively J. Biol. Chem. 276 2001 32714
7. N. Ferrara Molecular and biological properties of vascular endothelial growth factor J. Molec. Med. 77 1999 527
8. A. Damert, E. Ikeda, W. Risau Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells Biochem. J. 327 1997 419
9. J.A. Dibbens, D.L. Miller, A. Damert, W. Risau, M.A. Vadas, G.J. Goodall Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements Molec. Biol. Cell 10 1999 907
10. J. Rak, Y. Mitsuhashi, L. Bayko Mutant ras oncogenes upregulate VEGF/VPF expression Implications for induction and inhibition of tumor angiogenesis Cancer Res. 55 1995 4575
11. L.M. Ellis, C.A. Staley, W. Liu Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src J. Biol. Chem. 273 1998 1052
12. D. Mukhopadhyay, B. Knebelmann, H.T. Cohen, S. Ananth, V.P. Sukhatme The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity Molec. Cell. Biol. 17 1997 5629
13. L. Zhang, D. Yu, M. Hu Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression Cancer Res. 60 2000 3655
14. K.H. Plate, G. Breier, H.A. Weich, H.D. Mennel, W. Risau Vascular endothelial growth factor and glioma angiogenesis Coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms Int. J. Cancer 59 1994 520
15. Y. Takahashi, Y. Kitadai, C.D. Bucana, K.R. Cleary, L.M. Ellis Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer Cancer Res. 55 1995 3964
16. U. Eppenberger, W. Kueng Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients J. Clin. Oncol. 16 1998 3129
17. J.R. Woodburn The epidermal growth factor receptor and its inhibition in cancer therapy Pharmacol. Ther. 82 1999 241
18. D.S. Salomon, R. Brandt, F. Ciardiello, N. Normanno Epidermal growth factor-related peptides and their receptors in human malignancies Crit. Rev. Oncol. Hematol. 19 1995 183
19. L. Musallam, C. Ethier, P.S. Haddad, M. Bilodeau Role of EGF receptor tyrosine kinase activity in antiapoptotic effect of EGF on mouse hepatocytes Am. J. Physiol. Gastrointest. Liver Physiol. 280 2001 G1360
20. O. Alper, E.S. Bergmann-Leitner, T.A. Bennett, N.F. Hacker, K. Stromberg, W.G. Stetler-Stevenson Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells J. Natl. Cancer Inst. 93 2001 1375
21. F. Ciardiello, R. Caputo, R. Bianco Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor Clin. Cancer Res. 7 2001 1459
22. J. Baselga, D. Pfister, M.R. Cooper Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin J. Clin. Oncol. 18 2000 904
23. F. Ciardiello Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents Drugs 60 2000 25
24. R. Kerbel, J. Folkman Clinical translation of angiogenesis inhibitors Nat. Rev. Cancer. 2 2002 727
25. S.R. Wedge, D.J. Ogilvie, M. Dukes ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration Cancer Res. 62 2002 4645
26. F. Carlomagno, D. Vitagliano, T. Guida ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases Cancer Res. 62 2002 7284
27. R. Basser, H. Hurwitz, A. Barge Phase I pharmacokinetics and biological study of the angiogenesis inhibitor, ZD6474, in patients with solid tumors Proc. Am. Soc. Clin. Oncol. 37 2001 21
28. H. Minami, H. Ebi, M. Tahara A Phase I study of an oral VEGF receptor tyrosine kinase inhibitor ZD6474, in Japanese patients with solid tumors Proc. Am. Soc. Clin. Oncol. 22 2003 194 (abst 778)
29. H. Tanaka, H. Taniguchi, T. Mugitani Angiogenesis inhibitor TNP-470 prevents implanted liver metastases after partial hepatectomy in an experimental model without impairing wound healing Br. J. Surg. 83 1996 1444
30. S.A. Klein, S.J. Bond, S.C. Gupta, O.A. Yacoub, G.L. Anderson Angiogenesis inhibitor TNP-470 inhibits murine cutaneous wound healing J. Surg. Res. 82 1999 268
31. A.C. Berger, A.L. Feldman, M.F. Gnant The angiogenesis inhibitor, endostatin, does not affect murine cutaneous wound healing J. Surg. Res. 91 2000 26
32. L.B. Nanney, B.D. Wamil, J. Whitsitt CM101 stimulates cutaneous wound healing through an anti-angiogenic mechanism Angiogenesis 4 2001 61
33. C.D. Roman, H. Choy, L. Nanney Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in rats J. Surg. Res. 105 2002 43
34. J.M. Wood, G. Bold, E. Buchdunger PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration Cancer Res. 60 2000 2178
35. W.T. Lawrence, R.F. Diegelmann Growth factors in wound healing Clin. Dermatol. 12 1994 157
36. J.M. Peterson, A. Barbul, R.J. Breslin, H.L. Wasserkrug, G. Efron Significance of T-lymphocytes in wound healing Surgery 102 1987 300
37. J.E. Efron, H.L. Frankel, S.A. Lazarou, H.L. Wasserkrug, A. Barbul Wound healing and T-lymphocytes J. Surg. Res. 48 1990 460
38. T.L. Foutz, E.A. Stone, C.F. Abrams Jr Effects of freezing on mechanical properties of rat skin Am. J. Vet. Res. 53 1992 788
39. A. Quirinia, A. Viidik Freezing for postmortal storage influences the biomechanical properties of linear skin wounds J. Biomech. 24 1991 819
40. L. Hlatky, P. Hahnfeldt, J. Folkman Clinical application of antiangiogenic therapy Microvessel density, what it does and doesn't tell us J. Natl. Cancer Inst. 94 2002 883